Hillsdale Investment Management »

Ligand Pharmaceuticals In shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 42k 71.43
2023-09-30 $2.9M 48k 59.93
2023-06-30 $3.9M 54k 72.10

More positions owned by Hillsdale Investment Management

Celestica (CLS)
Docebo (DCBO)
Shopify Inc cl a (SHOP)
Lightspeed Comme (LSPD)
Rbc Cad (RY)
Manulife Finl Corp (MFC)
New Gold Inc Cda (NGD)
Ego (EGO)
Sun Life Financial (SLF)
Stantec (STN)
Primo Water (PRMW)
Kinross Gold Corp (KGC)
Cibc Cad (CM)
Cgi Inc Cl A Sub Vtg (GIB)
North American Const (NOA)

View all positions for Hillsdale Investment Management

Top funds holding Ligand Pharmaceuticals In

Vanguard Group
Henderson Group
Dimensional Fund Advisors
St. Denis J. Villere & Co
Pacer Advisors
Standard Life Aberdeen
Rice Hall James & Associates
Chicago Capital
Impax Asset Management Group
William Blair Investment Management
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of New York Mellon
Man Group
Kornitzer Capital Management

View all funds holding Ligand Pharmaceuticals In